All News


 

2020

August

Media Release / Aug 19, 2020

Sandoz Canada launches two new biosimilars Ziextenzo® and Riximyo®

Read More

July

Media Release / Jul 16, 2020

Novartis in Canada certified as a Great Place to Work® for a second consecutive year

Read More

June

Media Release / Jun 25, 2020

Sandoz Canada Launches The Biosimilars Generation

Read More
Media Release / Jun 24, 2020

Novartis In Canada once again named to the list of Best Workplaces TM in Quebec

Read More
Media Release / Jun 11, 2020

Sandoz Canada Launches Injectable PrAmoxicillin Sodium and Potassium Clavulanate for Hospital Use

Read More
Media Release / Jun 09, 2020

Sandoz Canada receives Health Canada approval to launch two oncology biosimilars: Ziextenzo® and Riximyo®

Read More
2019

July

Media Release / Jul 10, 2019

Novartis in Canada, including Sandoz Canada, proud to be Great Place to Work certified!

Read More

June

Media Release / Jun 12, 2019

Sandoz Canada launches PrHydrocortisone cream 2.5%

Read More

May

Media Release / May 27, 2019

BC PharmaCare’s Biosimilars Initiative an important step towards improving patient access to safe and effective medicines

Read More
Media Release / May 20, 2019

British Columbia adds Erelzi® (etanercept) to its PharmaCare drug plan for the treatment of psoriatic arthritis (PsA) in adult patients

Read More